rs2020955
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005236.3(ERCC4):āc.1984T>Cā(p.Ser662Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,613,574 control chromosomes in the GnomAD database, including 1,719 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_005236.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC4 | NM_005236.3 | c.1984T>C | p.Ser662Pro | missense_variant | 10/11 | ENST00000311895.8 | NP_005227.1 | |
ERCC4 | XM_011522424.4 | c.2122T>C | p.Ser708Pro | missense_variant | 11/12 | XP_011520726.1 | ||
ERCC4 | XM_047433774.1 | c.1195T>C | p.Ser399Pro | missense_variant | 7/8 | XP_047289730.1 | ||
ERCC4 | XM_011522427.2 | c.634T>C | p.Ser212Pro | missense_variant | 5/6 | XP_011520729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC4 | ENST00000311895.8 | c.1984T>C | p.Ser662Pro | missense_variant | 10/11 | 1 | NM_005236.3 | ENSP00000310520 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0588 AC: 8952AN: 152194Hom.: 903 Cov.: 32
GnomAD3 exomes AF: 0.0157 AC: 3954AN: 251158Hom.: 329 AF XY: 0.0120 AC XY: 1631AN XY: 135712
GnomAD4 exome AF: 0.00669 AC: 9778AN: 1461262Hom.: 815 Cov.: 30 AF XY: 0.00588 AC XY: 4273AN XY: 726982
GnomAD4 genome AF: 0.0589 AC: 8967AN: 152312Hom.: 904 Cov.: 32 AF XY: 0.0561 AC XY: 4178AN XY: 74482
ClinVar
Submissions by phenotype
Xeroderma pigmentosum, group F Benign:2
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2019 | - - |
not specified Benign:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at